Skip to content
Bored Studies
RecruitingAccepts healthy volunteers

Collection of Samples USOPTIVAL Study

Universal Diagnostics · NCT04792684

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 45–84 · All sexes
Healthy volunteers
Accepted
Study type
Observational
Target enrollment
1300
US sites recruiting
4
Study start
December 30, 2020
Record last updated
November 10, 2025

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

A prospective multi-center observational study. The study will enroll eligible subjects from the United States to optimize the biomarker panel and evaluate the performance of a cfDNA marker panel selected by the Sponsor for CRC and advanced adenoma detection.

Being studied: Optimization of Plasma Circulating Free-DNA (cfDNA) Marker Panel

Conditions: Colorectal Cancer (CRC); Advanced Adenomas (AA)

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

Arm A

  • Must be 45-84 years of age.
  • Must have a suspected advanced adenoma or be newly diagnosed with CRC, still not resected, and scheduled for surgery.
  • Able to comprehend, sign, and date the written informed consent document.

Arm B

  • Must be 45-84 years of age.
  • Able and willing to undergo a standard-of-care screening colonoscopy within 60 days.
  • Able to comprehend, sign, and date the written informed consent document.

Exclusion Criteria

Arm A Only

  • Subject with curative biopsy during colonoscopy.

Arm B Only

  • Subjects with positive FIT Test results in the 6 months preceding enrollment.
  • Subject has a current diagnosis of cancer.

Arms A \& B:

  • Subject has a personal history of aerodigestive or digestive tract cancers.
  • Subjects having undergone previous partial surgical removal of one or more portions of their colon due to a reason other than colorectal cancer.
  • Has a known diagnosis or personal history of any of the following high-risk indications for colorectal cancer:
  • Inflammatory bowel disease (IBD) including chronic ulcerative colitis (CUC) and Crohn's disease.
  • Familial adenomatous polyposis ("FAP", including attenuated FAP).
  • Hereditary non-polyposis colorectal cancer syndrome ("HNPCC" or "Lynch Syndrome").
  • Serrated polyposis syndrome
  • 2 first-degree relatives (e.g., parents, siblings, and offspring) who have been diagnosed with colon cancer.
  • One first-degree relative with CRC diagnosed before the age of 60.
  • A significant disease which, in the Investigator's opinion, would exclude the subject from the study.
  • Legal incapacity or limited mental capacity.
  • Medical or psychological conditions that would not permit the subject to complete the study or sign informed consent.
  • The patient has a known or documented previous or current medical history of infectious diseases that can be transmitted through blood (E.g. Hepatitis, HIV, etc.), including patients that have been treated, are currently being treated, or have not been treated for that conditions.
  • The patient is known to be pregnant when recruited or during her participation in the study.

Recruiting US locations

  • Lakeland Regional Cancer Center

    Lakeland, FL 33805

    Site contact: Manuel Molina

  • Springfield Clinic

    Springfield, IL 62702

    Site contact: Peter Hofmann

  • Mid Hudson Medical Research

    New Windsor, NY 12553

    Site contact: Sashi Makam

  • University of Pennsylvania

    Philadelphia, PA 19104

    Site contact: Bryson Katona

Study contacts (from the official record)

  • Antonio Jesus Merino Calvo · (+34)674945571 · antonio.merino@universaldx.com
Collection of Samples USOPTIVAL Study (NCT04792684) | Bored Studies